TTOO News and Press, T2 Biosystems Inc. From 04/26/23

LEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted new clinical data supporting the T2Bacteria® Panel and the T2Candida® Panel, that w...

LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the availability of a new webinar and white paper highlighting the T2Candida ® Panel c...

2023-03-24 15:03:29 ET Penny stock investing offers potential rewards and volatility. Generally, penny stocks are valued below $5 and can be risky, but they provide substantial gains for risk-tolerant investors. As March 2023 concludes, the stock market faces turbulence due to the recen...

2023-03-23 10:12:12 ET T2 Biosystems ( NASDAQ: TTOO ) confirmed its plans to add detection of fungal pathogen Candida auris to its FDA-cleared and CE marked T2Candida Panel. A rare and often deadly fungal species is spreading across the U.S. The fungus, a type of...

LEXINGTON, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today affirmed plans to add detection of the fungal pathogen Candida auris to the Company’s FDA-clea...

2023-03-13 18:46:03 ET T2 Biosystems, Inc. (TTOO) Q4 2022 Earnings Conference Call March 13, 2023, 04:30 PM ET Company Participants John Sperzel - Chairman and CEO John Sprague - CFO Conference Call Participants Mark Massaro - BTIG Ben Haynor - Allian...

2023-03-13 16:07:26 ET T2 Biosystems press release ( NASDAQ: TTOO ): Q4 GAAP EPS of -$1.41 beats by $0.92 . Revenue of $5.48M (-21.5% Y/Y) beats by $0.08M . Achieved record full year 2022 sepsis-driven T2Dx ® Instrument placements, totaling 51 contract...

LEXINGTON, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the fourth quarter and full year ended Dece...

2023-03-12 18:35:00 ET T2 Biosystems ( NASDAQ: TTOO ) is scheduled to announce Q4 earnings results on Monday, March 13, after market close. The consensus EPS Estimate is -$2.33 and the consensus Revenue Estimate is $5.4M (-22.6% Y/Y). Over the last 3 months, EPS estima...

LEXINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the fourth quarter and full year 2022 after market cl...